Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy Finke

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
JCO Precision Oncology|July 8, 2024
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective StudyYael Kusne, Terra Lasho, Christy Finke, et al.
Blood Cancer Journal|November 21, 2018
Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlatesNatasha Szuber, Sravanthi Lavu, Mythri Mudireddy, et al.
Leukemia|March 30, 2022
Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemiaConnor Walsh, Anthony Hunter, Terra Lasho, et al.
Leukemia|March 25, 2023
Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesisTerra Lasho, Christy Finke, Michael Timm, et al.
Blood|October 1, 2024
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutationsZhuoer Xie, Jenna Fernandez, Terra Lasho, et al.
Leukemia Research|December 31, 2022
Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort studyStephanie L Pritzl, Mark Gurney, Talha Badar, et al.
Haematologica|August 30, 2023
Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapyZhuoer Xie, Terra Lasho, Arushi Khurana, et al.
Leukemia Research|March 2, 2022
Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMMLZhuoer Xie, Gina Campestri, Terra Lasho, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2023
Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery DiseaseNadia Akhiyat, Terra Lasho, Morsaleh Ganji, et al.
Blood Advances|November 20, 2020
SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survivalKitsada Wudhikarn, Sanam Loghavi, Abhishek A Mangaonkar, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
JCO Precision Oncology|July 8, 2024
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective StudyYael Kusne, Terra Lasho, Christy Finke, et al.
Blood Cancer Journal|November 21, 2018
Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlatesNatasha Szuber, Sravanthi Lavu, Mythri Mudireddy, et al.
Leukemia|March 30, 2022
Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemiaConnor Walsh, Anthony Hunter, Terra Lasho, et al.
Leukemia|March 25, 2023
Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesisTerra Lasho, Christy Finke, Michael Timm, et al.
Blood|October 1, 2024
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutationsZhuoer Xie, Jenna Fernandez, Terra Lasho, et al.
Leukemia Research|December 31, 2022
Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort studyStephanie L Pritzl, Mark Gurney, Talha Badar, et al.
Haematologica|August 30, 2023
Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapyZhuoer Xie, Terra Lasho, Arushi Khurana, et al.
Leukemia Research|March 2, 2022
Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMMLZhuoer Xie, Gina Campestri, Terra Lasho, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2023
Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery DiseaseNadia Akhiyat, Terra Lasho, Morsaleh Ganji, et al.
Blood Advances|November 20, 2020
SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survivalKitsada Wudhikarn, Sanam Loghavi, Abhishek A Mangaonkar, et al.
Pageof 6